Document is current
Any future updates will be listed below
-
Authors
Drejeriene, Ieva
Gruode, Jurate
Cicenas, Saulius
Loizides, Charalambos
Eliades, Alexia
Achilleos, Achilleas
Kypri, Elena
Tsangaras, Kyriakos
Ioannides, Marios
Koumbaris, George
Stanciute, Diana
Krasauskas, Arnoldas
Patsalis, Philippos C.
- License Information
-
More Information
Article History
Received: 27 March 2024
Accepted: 18 September 2024
First Online: 18 December 2024
Declarations
:
: CL: Employed by MEDICOVER Genetics has filed a PCT patent application for Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1); AA: Employed by MEDICOVER Genetics; has filed a PCT patent application for the Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1); has filed a PCT patent application for the Enrichment of Targeted Genomic Regions for Multiplexed Par-allel Analysis (WO2019/008148A9); EK: Employed by MEDICOVER Genetics; has filed a PCT pa-tent application for the Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1); has filed a PCT patent application for the Enrichment of Tar-geted Genomic Regions for Multiplexed Parallel Analysis (WO2019/008148A9); KT: Employed by MEDICOVER Genetics, has filed a PCT patent application for the Enrichment of Targeted Ge-nomic Regions for Multiplexed Parallel Analysis (WO2019/008148A9); AE: Employed by MEDI-COVER Genetics; has filed a PCT patent application for the Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1); MI: Employed by MEDICOV-ER Genetics; has filed a PCT patent application for the Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1), has filed a PCT patent applica-tion for the Enrichment of Targeted Genomic Regions for Multiplexed Parallel Analysis (WO2019/008148A9); GK: Employed by MEDICOVER Genetics; has filed a PCT patent application for the Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1); has filed a PCT patent application for the Enrichment of Targeted Genomic Regions for Multiplexed Parallel Analysis (WO2019/008148A9); PCP: Employed by MEDICOVER Genetics; has filed a PCT patent application for the Target-enriched multiplexed parallel analysis for assessment of tumor biomarkers (WO2019/008172A1); has filed a PCT patent application for the Enrichment of Targeted Genomic Regions for Multiplexed Parallel Analysis (WO2019/008148A9); The rest of the authors declare no conflict of interest.
